Hostname: page-component-84b7d79bbc-g7rbq Total loading time: 0 Render date: 2024-07-26T13:13:34.502Z Has data issue: false hasContentIssue false

Case Reports of Inhaled Loxapine in the Treatment of Agitated Patients

Published online by Cambridge University Press:  15 April 2020

T. Messer
Affiliation:
Psychiatry, Danuvius Klinik GmbH, Pfaffenhofen an der Ilm, Germany
M. Knappich
Affiliation:
Psychiatry, Danuvius Klinik GmbH, Pfaffenhofen an der Ilm, Germany

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Agitation is a broadly defined phenomenon that is associated with many physical and mental illnesses. The core features of agitation generally include: irritability, excessive or semi purposeful motor activity, heighted responsiveness to internal and external stimuli and an unstable course. Inhaled Loxapine is recently available as a new approach in the management of these episodes.

Objective

To present case reports of Inhaled Loxapine in the treatment of agitated patients in our clinic.

Method

We have selected representative case reports form our acute unit characterizing the patients´ history and the circumstances of present admission, the evolution and the management of these episodes during the admission.

Conclusion

Inhaled loxapine as a new treatment option allows rapid control of agitation in these unstable patients who can suddenly turn into aggression or violence, facilitating the therapeutic alliance between the patient and physician without resorting to mechanical or physical restraint.

Type
Article: 0651
Copyright
Copyright © European Psychiatric Association 2015
Submit a response

Comments

No Comments have been published for this article.